Literature DB >> 20670426

Struma ovarii associated with pseudo-Meigs' syndrome and elevated serum CA 125: a case report and review of the literature.

Wei Jiang1, Xin Lu, Zhi Ling Zhu, Xi Shi Liu, Cong Jian Xu.   

Abstract

The association of pseudo-Meigs' syndrome, elevation of CA 125 to the struma ovarii is a rare condition. So far only nine cases have been reported in English literature through MEDLINE search. Here we report a 46-year-old case of the struma ovarii, presented with ascites, hydrothorax, right ovarian mass and elevated serum CA 125 level. These findings were misdiagnosed for an ovarian malignancy at the first impression. Immediate resolution of the ascites, hydrothorax and normalization of the serum CA 125 level were followed by ovarian mass removal. Struma ovarii could be a rare cause of ascites, hydrothorax, ovarian mass and elevated CA 125. This rare condition should be considered in the differential diagnosis in patents with ascites and pleural effusions but with negative cytology.

Entities:  

Year:  2010        PMID: 20670426      PMCID: PMC2923141          DOI: 10.1186/1757-2215-3-18

Source DB:  PubMed          Journal:  J Ovarian Res        ISSN: 1757-2215            Impact factor:   4.234


  15 in total

1.  Struma ovarii with pseudo-Meigs' syndrome and elevated CA125 levels.

Authors:  B R Obeidat; Z O Amarin
Journal:  J Obstet Gynaecol       Date:  2007-01       Impact factor: 1.246

2.  Struma ovarii showing clinical characteristics of ovarian malignancy.

Authors:  S Y Rim; S M Kim; H S Choi
Journal:  Int J Gynecol Cancer       Date:  2005 Nov-Dec       Impact factor: 3.437

3.  Pseudo-Meigs syndrome and elevated CA125 associated with struma ovarii.

Authors:  Vera Loizzi; Gennaro Cormio; Leonardo Resta; Nicola Fattizzi; Mario Vicino; Luigi Selvaggi
Journal:  Gynecol Oncol       Date:  2005-04       Impact factor: 5.482

4.  Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.

Authors:  W Glenn McCluggage; John P Bissonnette; Robert H Young
Journal:  Int J Gynecol Pathol       Date:  2006-10       Impact factor: 2.762

5.  An unusual presentation of struma ovarii mimicking a malignant process.

Authors:  Vera Loizzi; Fabio Cappuccini; Michael L Berman
Journal:  Obstet Gynecol       Date:  2002-11       Impact factor: 7.661

6.  Pseudo-Meigs syndrome and elevated levels of tumor markers associated with benign ovarian tumors--two case reports.

Authors:  C Y Long; Y H Chen; S C Chen; J N Lee; J H Su; S C Hsu
Journal:  Kaohsiung J Med Sci       Date:  2001-11       Impact factor: 2.744

7.  Struma ovarii associated with pseudo-Meigs' syndrome and elevated serum CA 125.

Authors:  Julie J Huh; F J Montz; Robert E Bristow
Journal:  Gynecol Oncol       Date:  2002-08       Impact factor: 5.482

8.  Limitations of CA125 in the preoperative evaluation of a pelvic mass: struma ovarii and ascites.

Authors:  Y C Leung; I G Hammond
Journal:  Aust N Z J Obstet Gynaecol       Date:  1993-05       Impact factor: 2.100

9.  Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case report.

Authors:  Gian Franco Zannoni; Valerio Gallotta; Francesco Legge; Elisabetta Tarquini; Giovanni Scambia; Gabriella Ferrandina
Journal:  Gynecol Oncol       Date:  2004-07       Impact factor: 5.482

Review 10.  Cystic struma ovarii presenting as pseudo-Meigs' syndrome with elevated CA125 levels. A case report and review of the literature.

Authors:  S Mitrou; S Manek; S Kehoe
Journal:  Int J Gynecol Cancer       Date:  2008 Mar-Apr       Impact factor: 3.437

View more
  9 in total

1.  Pseudo-Meigs' syndrome associated with struma ovarii.

Authors:  Ali Kemal Sivrioglu; Muzaffer Saglam; Guner Sonmez; Mehmet Deveer
Journal:  BMJ Case Rep       Date:  2013-04-23

Review 2.  Struma Ovarii with Pseudo-Meigs' Syndrome and Raised Cancer Antigen-125 Levels Masquerading as an Ovarian Carcinoma Case report and literature review.

Authors:  Surekha Yadav; Reena Tomar; Nidhi Verma; Nita Khurana; Rewa Triathi
Journal:  Sultan Qaboos Univ Med J       Date:  2017-06-20

3.  Meigs' syndrome with elevated serum CA125 in a case of ovarian fibroma /thecoma.

Authors:  Shahla Yazdani; Abolhasan Alijanpoor; Majid Sharbatdaran; Zinatossadat Bouzari; Mohammad Abedisamakoosh; Faranak Lakaieandi; Mehdi Mohammadpour
Journal:  Caspian J Intern Med       Date:  2014

4.  Bilateral Ovarian Fibrothecoma Associated with Ascites, Bilateral Pleural Effusion, and Marked Elevated Serum CA-125.

Authors:  Védi André Serges Loué; Eléonore Gbary; Sylvanus Koui; Bédi Akpa; Adélaide Kouassi
Journal:  Case Rep Obstet Gynecol       Date:  2013-02-03

5.  Struma ovarii associated with Pseudo-Meig's syndrome and high serum level of CA 125; a case report.

Authors:  Nahid Mostaghel; Anahita Enzevaei; Khandan Zare; Masoome Fallahian
Journal:  J Ovarian Res       Date:  2012-03-21       Impact factor: 4.234

6.  Coexistence of benign struma ovarii, pseudo-Meigs' syndrome and elevated serum CA 125: Case report and review of the literature.

Authors:  Chengjuan Jin; Ruiying Dong; Hualei Bu; Mingyuan Yuan; Youzhong Zhang; Beihua Kong
Journal:  Oncol Lett       Date:  2015-02-03       Impact factor: 2.967

7.  Treatment and follow-up of malignant struma ovarii: Regarding two cases.

Authors:  Aurore Oudoux; Eric Leblanc; Juliette Beaujot; Hélène Gauthier-Kolesnikov
Journal:  Gynecol Oncol Rep       Date:  2016-06-08

8.  Struma Ovarii Associated with Ascites and Elevated CA125: Two Case Reports and Review of the Literature.

Authors:  Shaoyu Wang; Xinqin He; Huijuan Yang; Lihong Chen
Journal:  Int J Womens Health       Date:  2022-09-07

Review 9.  Precise preoperative diagnosis of struma ovarii with pseudo-Meigs' syndrome mimicking ovarian cancer with the combination of 131I scintigraphy and 18F-FDG PET: case report and review of the literature.

Authors:  Sayaka Fujiwara; Hideaki Tsuyoshi; Toshiya Nishimura; Nozomu Takahashi; Yoshio Yoshida
Journal:  J Ovarian Res       Date:  2018-02-02       Impact factor: 4.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.